A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature

Table 1 Laboratory data of the patient with invasive giant prolactinoma

Items	Results	Reference value and normal range	Units
GH	0.40	0.03–2.47	ng/ml
IGF-1	145.35	111.4–256.8	ng/ml
TSH	1.55	0.27–4.2	mIU/L
FT3	4.01	3.60–7.50	pmol/L
FT4	13.56	12.0–22.0	pmol/L
ACTH	24.30	5.0–78.0	ng/L
PTC	496.90	147.3–609.3	nmol/L
LH	2.6	1.7–8.6	mIU/mL
FSH	3.9	1.5–12.4	mIU/mL
E2	9.59	25.8–60.7	pg/mL
P	0.23	0.05–0.149	ng/mL
PRL	> 4700	4.6–21.4	ng/mL
T	2.77	2.49–8.36	ng/mL
DHEAs	1.59	1.2–8.98	umol/L

PRL Preoperative routine examination of pituitary and target-glands related hormones, serum prolactin, GH Growth hormone, IGF-1 Insulin-like growth factor-1, TSH Thyroid-stimulating hormone, FT3 Free triiodothyronine, FT4 Free thyroxine, ACTH Adrenocorticotropic hormone, PTC-8:00 8:00 am plasma cortisol, LH Luteinizing hormone, FSH Follicle-stimulating hormone, E2 Estradiol, P Progesterone, T Testosterone, DHEA-S Dehydroepiandrosterone sulfate

ISSN: 1472-6823